AHA executive calls SGR system “terribly flawed” and proposes new payment system

CHICAGO – If Congress does not act in the coming weeks, physician payments for treating Medicare patients will decrease by 21 percent on April 1.

This is the 17th time doctors are facing a potential pay cut, according to Richard Pollack, executive vice president for advocacy and public policy at the American Hospital Association. Pollack spoke Tuesday at the American College of Healthcare Executives’ Congress on Healthcare Leadership.

Congress created the sustainable growth rate (SGR) system in 1997 to tie Medicare payments to the growth of the economy, but health costs have increased at a far higher rate than the economy in the past decade. Congress has repeatedly passed “doc fix” bills to increase Medicare funding, but it had not done so as of Tuesday.

Pollack called the SGR system “terribly flawed” and said there is bipartisan agreement that it should be overhauled and replaced with value-based purchasing or another payment model.

“Everyone says we need to get rid of this system,” he said.

The AHA also does not want another delay in ICD-10 implementation, according to Pollack. As of now, the Centers for Medicare & Medicaid Services is requiring everyone covered by HIPAA to use ICD-10, which does not apply to CPT coding for outpatient procedures and physician services.

ICD-10 was most recently delayed in March 2014 when Congress approved a temporary “doc fix” for the SGR payment system.

“It’s time to move forward, but you never know when a delay will pop up,” Pollack said.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.